recorded for 231 patients; in this regard, it is important to specify that in our routine not all excised lymph nodes were analysed. However, a limited number of nodes are randomly sampled by a pathologist (mean 5.6; range 0-21).
Data collection and follow-up. Data were retrospectively collected by chart review by physicians and physician assistants. Among others, data regarding personal and medical information, surgery, post-operative course, histopathologic examination were collected and stored in a database. Survival status and eventual date and cause of death were collected through the Latvia Cancer Registry. The median follow-up period for surviving patients was 57.5 (range 29-89) months.
Statistical analysis. The Chi-square test was used for categorical data and the ANOVA test for continuous variables. Survival curves were estimated using the KaplaneMeier method and compared by the log-rank test. Death from causes other than gastric cancer was considered censored observations at the time of death. Each demise occurring in-hospital or within 30 days was considered as postoperative mortality and used in survival analysis. Statistical analyses were performed using Statistical Product and Service Solutions, SPSS 14.0 for Windows, XP, SPSS Inc., Chicago IL.
RESULTS
Population under study. During the study period, 461 patients underwent resection with curative intent (R0-R1). On average, 92.2 (range 81-102) R0-R1 gastrectomies were performed each year. Median age of the cohort was 65 years (range 23-89) with a male to female ratio of 1.2 : 1.
Short-term results.
Postoperative general and surgical complications occurred in 75 patients (16.3%) and, of these 15 consequently died (post-operative mortality, 3.3%). Morbidity complicated post-operative course in 36 total gastrectomies, 34 subtotal gastrectomies and four proximal gastrectomies (P < 0.05). Mortality was slightly higher for total gastrectomy (4.8%) compared to subtotal (2%) and proximal resections (4%) (P < 0.05).
Survival according to completeness of tumour resection (R classification).
The overall median survival time for the 461 patients was beyond the observation period with 2-and 5-year survival rates of 63.9% and 50.8%. In 444 cases there was histopathologic confirmation of curative resection (R0), while a microscopic residual tumour (R1) was demonstrated in 17 cases. When R0 resection was obtained the 5-year survival was 52.5% while the survival rate fell to 5.9% at 43 months (median, 9.4 months) when a residual tumour was observed (P < 0.001).
Survival according to tumour location and depth of tumour invasion (pT).
Survival curves for R0-resected patients according to tumour location are depicted in Figure 1 . Figure 2 shows Kaplan-Meier estimates of survival probability according to the depth of tumour invasion (pT).
Survival according to lymph node involvement (pN).
Considering nodal involvement, the 5-year survival rate was 67% for pN0 patients, 30% for pN1 and 29% for pN2-3 (P < 0.05). Restricting the analysis to pN+ cases, no difference was demonstrated between pN1 and pN2-3 subsets (P < 0.05) (Fig. 3) . 
DISCUSSION
Major findings. Major findings of this study are: 1) morbidity and mortality are similar to those reported by high volume centres in Western Europe and United States, and 2) survival rates are almost equal, particularly for patients with nodal involvement, for which no significant difference was found between pN1 and pN2-3 cases.
Gastric cancer in Latvia. The Latvian Cancer Registry data was used to preview gastric cancer incidence in Latvia for the time period 1980-2007 (Fig. 4) and mortality for time period 1991-2007 (Fig. 5) . The proportions of stages of new gastric cancer cases in Latvia for 2001-2007 are shown in Table 1 . Five-year observed survival for patients with gastric cancer in Latvia in percent was examined for the time period [1988] [1989] [1990] [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] (Fig. 6) . Although the incidence of gastric cancer and mortality caused by this malignancy are decreasing in Latvia, the rates are still considerably higher than on average in the EU. While the number of gastroscopies is increasing the proportion of early diagnosed new gastric cancer cases is still low. Radical resection still remains the mainstay of therapy for gastric cancer and, unfortunately, only a minority of Latvia patients match oncologic criteria to undergo surgery with curative intent.
Results of surgery.
In spite of the very advanced stage in the great majority of Latvia patients, clinico-pathological characteristics of gastric cancer cases resected with curative intent are comparable with those of Western Europe and North America (Songun et al., 1996) . Particularly, the number of patients with positive resection margins is well above 5%, similar to that reported in the literature (Songun et al., 1996; Fujimoto et al., 1997; Sano and Mudan, 1999) . The small number of R1-patients and the overall 5-year survival rate, which approaches 50%, provides evidence of the quality of surgical treatment in this setting. Above all, long-term results were positively influenced by the low morbidity and mortality observed in this series.
Assessment of adjacent organ invasion.
Considering depth of tumour invasion, serosal invasion is typical for the majority of tumours (62.5%). Regarding pT4 cases (18%), there may have been inaccurate determination of intraoperative stage related to overestimation by the operating sur- Fig. 3 . Kaplane-Meier estimates of survival probability according to nodal involvement (pN) in 444 patients who underwent R0 gastrectomy. Median (95% CI) survival time was beyond the observation period for pN0 tumours; 22.1 (18.1-26.1) months for pN1 tumours and 14.2 (9.7-18.7) months for pN2-3 tumours; (P < 0.001). geons (and pathologic stage) as well as from the retrospective nature of data collection. This seems to be confirmed by the unexpected 5-year survival rate of 27% observed in pT4 cases (Fig. 2) (Nanthakumaran et al., 2005; Kunisaki et al., 2006) .
Assessment of nodal involvement.
Regarding nodal involvement (pN), a very high rate of node negative patients was observed (61%) (Harrison et al., 1998; Roviello et al., 2002; Di Leo et al., 2007) . Among pN+ patients, the great majority of patients showed 1-6 positive nodes, 22% had 7-15 metastatic nodes and only one more than 15 nodes. These results may be related to the very low number of analysed nodes, usually five or less (mean, 5.6; range, 0-21) . In the present study only 24 patients had more than ten analysed nodes and four more than 15. This may have caused determination of imprecise nodal stage, as demonstrated from the lack of survival difference between pN1 and pN2 cases (Fig. 3) . The low number of examined nodes seems to be due, over and above surgical technique, to a perceived lack of need by pathologists to retrieve more lymph nodes from resected specimens. This conclusion is supported by survival results that are comparable to other European and United States high volume centres (Edwards et al., 2004; Enzinger et al., 2007) , although they are not as good as those reported after extended lymphadenectomy (Siewert et al., 1993; Maeta et al., 1999; Roviello et al., 2002; Sasako et al., 2008) .
In conclusion, our data confirm that the strategy to concentrate gastric cancer surgery in high volume centres with relevant expertise has been a correct approach in our country and should be recommended as a standard. The results indicate the need to improve histopathological examination of stage and extent of lymphadenectomy.
